Limited Liability Company (LLC)
Biotermo Develop
Biotermo Develop Spółka z Ograniczoną Odpowiedzialnością
Limited Liability Company (LLC)
Biotermo Develop Spółka z Ograniczoną Odpowiedzialnością
Biotermo Develop Spółka z Ograniczoną Odpowiedzialnością (KRS 0001096170, NIP 9710734176) is a Polish company, headquartered in Osada, Mazowieckie voivodeship. Biotermo Develop operates in: Development of building projects (PKD 41.10.Z). Industry: Building construction. The company has been listed in the National Court Register since March 25, 2024.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Other activities
Founded
March 25, 2024
2 years in operation
Legal form
Limited Liability Company (LLC)
Registry: RejP
Headquarters
OSADA
MAZOWIECKIE
Primary PKD
41.10.Z
Development of building projects
Share capital
5.0 K PLN
100 shares total
Shareholders
2
shareholders
Board
2 people
Registry entries
4
latest: April 22, 2025
No KPI data - financial statements and valuation are unavailable for this company.
People holding roles at Biotermo Develop according to the Polish National Court Register. Follow a name for that person's full profile and their other companies.
Rate business credibility - Biotermo Develop.
No ratings

News
Cieszyn-based Atal S.A. (KRS 0000262397) closed 2025 with revenue of PLN 1.267bn, net profit of PLN 223.3m and a 17.6% net margin. The board recommends a PLN 4.50 per-share dividend (88% of profit, PLN 194.67m in total, ~8.6% yield) – lower than the PLN 6.00 paid from 2024 profit but still among the highest in the Polish residential-development sector. Q1 2026 saw handovers double (500 vs 218 YoY); the 2026 targets are 2,500–3,000 units sold and 3,000–4,000 handed over. Juroszek Holding controls 76.30% of the capital.

Explainer
Develia S.A. (KRS 0000253077), headquartered at ul. Gen. Romualda Traugutta 45 in Wrocław, is one of Poland's largest residential developers listed on the WSE. The company has operated under the "Develia" brand since 2019 (previously as LC Corp, part of Leszek Czarnecki's group). Listed on the WSE since 2007, it is an mWIG40 constituent with a four-member management board and a seven-member supervisory board. Per the 2025 financial statements: PLN 2.08bn revenue (+16% YoY) and PLN 443.5m net profit.
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
Biotermo Develop has 2 shareholders.
No - Biotermo Develop's share capital is split between several shareholders.
Biotermo Develop's board has 2 members.
Latest reporting year
2024
Available years
1
Filing entries
0
4 historical registry entries for Biotermo Develop
Registration in the Polish National Court Register
LD.XX NS-REJ.KRS/9550/24/763
Identifier change
LD.XX NS-REJ.KRS/9550/24/763/NIP
Identifier change
LD.XX NS-REJ.KRS/9550/24/763/REGON
Filing document
Competing companies or those operating in the same market segment as Biotermo Develop (industry: Building construction).
WARSZAWA· Building construction
Revenue 2021: 9.3 M PLN
PIASTÓW· Building construction
Revenue 2023: 3.5 M PLN
JANKI· Building construction
Revenue 2024: 0 PLN
WARSZAWA· Building construction
Revenue 2024: 0 PLN
WARSZAWA· Building construction
Revenue 2024: 0 PLN
WARSZAWA· Building construction
Revenue 2024: 0 PLN